Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M0.4Revenue (TTM) $M49.1Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $1.4Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M8.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SKBI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

SKBI is held by these investors:

SKBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GREGORY JOHN M10% Owner 2015-05-26Buy63,900$2.91-99.66view
GREGORY JOHN M10% Owner 2015-05-06Buy50,000$3.47-99.71view
GREGORY JOHN M10% Owner 2015-04-16Buy35,000$3.82-99.74view
GREGORY JOHN M10% Owner 2015-02-02Buy38,730$4.21-99.76view
GREGORY JOHN M10% Owner 2014-12-23Buy70,800$4.28-99.77view
GREGORY JOHN M10% Owner 2014-12-10Sell0$0-99.77view
GREGORY JOHN M10% Owner 2014-12-10Buy103,016$4.56-99.78view

Press Releases about SKBI :

Quarterly/Annual Reports about SKBI:

    News about SKBI:

    Articles On GuruFocus.com
    Skystar Bio-Pharmaceutical Announces Final Delisting From Nasdaq and Continued Trading on OTC Pink U Feb 26 2016 
    Skystar Bio-Pharmaceutical Company Update Dec 22 2015 
    Skystar Bio-Pharmaceutical Company Announces Delisting From NASDAQ Dec 18 2015 
    Skystar Bio-Pharmaceutical Company Receives Approval for T-Factor Animal Supplement Patent From PRC' Oct 27 2015 
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Notification Letter Oct 23 2015 
    Skystar Bio-Pharmaceutical Company Provides Investor Update Regarding Delay in Filing Form 10-K Oct 02 2015 
    Skystar Bio-Pharmaceutical Company Announces Receipt of Nasdaq Non-Compliance Letter Due to Delay in Aug 25 2015 
    Skystar Bio-Pharmaceutical to File Financial Results for Third Quarter of Fiscal 2014 on Friday, Nov Nov 14 2014 
    Skystar Bio-Pharma Featured on Wide World of Stocks Television Nov 05 2014 

    More From Other Websites
    No related articles found.

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat